MX2023001905A - Vacunas vivas liofilizadas de bordetella. - Google Patents
Vacunas vivas liofilizadas de bordetella.Info
- Publication number
- MX2023001905A MX2023001905A MX2023001905A MX2023001905A MX2023001905A MX 2023001905 A MX2023001905 A MX 2023001905A MX 2023001905 A MX2023001905 A MX 2023001905A MX 2023001905 A MX2023001905 A MX 2023001905A MX 2023001905 A MX2023001905 A MX 2023001905A
- Authority
- MX
- Mexico
- Prior art keywords
- bordetella bacteria
- bordetella
- dried
- bacteria
- freeze
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063066020P | 2020-08-14 | 2020-08-14 | |
| PCT/US2021/046055 WO2022036298A1 (en) | 2020-08-14 | 2021-08-15 | Lyophilized live bordetella vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023001905A true MX2023001905A (es) | 2023-03-13 |
Family
ID=80247370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023001905A MX2023001905A (es) | 2020-08-14 | 2021-08-15 | Vacunas vivas liofilizadas de bordetella. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230173053A1 (enExample) |
| EP (1) | EP4196155A4 (enExample) |
| JP (1) | JP7809362B2 (enExample) |
| KR (1) | KR20230051186A (enExample) |
| CN (1) | CN116322756A (enExample) |
| AU (1) | AU2021325149A1 (enExample) |
| BR (1) | BR112023002549A2 (enExample) |
| CA (1) | CA3187934A1 (enExample) |
| CL (1) | CL2023000451A1 (enExample) |
| CO (1) | CO2023002823A2 (enExample) |
| MX (1) | MX2023001905A (enExample) |
| WO (1) | WO2022036298A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2215033C2 (ru) * | 2001-06-27 | 2003-10-27 | Научно-исследовательский институт микробиологии МО РФ | Способ получения концентрата микробных клеток в производстве чумных вакцин |
| EP1708747A2 (en) * | 2004-01-15 | 2006-10-11 | Intervet International BV | Non-animal origin stabilizers and processes for producing the same |
| US9119804B2 (en) | 2006-03-10 | 2015-09-01 | Institut Pasteur De Lille | Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| EP2722338A1 (en) | 2012-10-17 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel recombinant Bordetella strains |
| AR097762A1 (es) * | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| EP4541809A3 (en) | 2016-03-29 | 2025-06-25 | Institut Pasteur de Lille | Mutant bordetella strains and methods of use |
| RU2709657C2 (ru) * | 2017-08-07 | 2019-12-19 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) | Способ лиофильного высушивания аттенуированных бактерий B. pertussis, аттенуированная бактерия B. pertussis, штамм аттенуированных бактерий B. Pertussis, вакцина, лиофилизированный вакцинный препарат |
| WO2020049133A1 (en) | 2018-09-05 | 2020-03-12 | National University Of Singapore | Adenylate cyclase catalytic domain deficient bordetella strains |
-
2021
- 2021-08-15 AU AU2021325149A patent/AU2021325149A1/en active Pending
- 2021-08-15 BR BR112023002549A patent/BR112023002549A2/pt unknown
- 2021-08-15 EP EP21856843.4A patent/EP4196155A4/en active Pending
- 2021-08-15 CA CA3187934A patent/CA3187934A1/en active Pending
- 2021-08-15 MX MX2023001905A patent/MX2023001905A/es unknown
- 2021-08-15 KR KR1020237004612A patent/KR20230051186A/ko active Pending
- 2021-08-15 JP JP2023510359A patent/JP7809362B2/ja active Active
- 2021-08-15 WO PCT/US2021/046055 patent/WO2022036298A1/en not_active Ceased
- 2021-08-15 CN CN202180055776.1A patent/CN116322756A/zh active Pending
-
2023
- 2023-01-25 US US18/159,550 patent/US20230173053A1/en active Pending
- 2023-02-14 CL CL2023000451A patent/CL2023000451A1/es unknown
- 2023-03-07 CO CONC2023/0002823A patent/CO2023002823A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230173053A1 (en) | 2023-06-08 |
| CA3187934A1 (en) | 2022-02-17 |
| JP7809362B2 (ja) | 2026-02-02 |
| WO2022036298A1 (en) | 2022-02-17 |
| JP2023540453A (ja) | 2023-09-25 |
| AU2021325149A1 (en) | 2023-03-02 |
| CN116322756A (zh) | 2023-06-23 |
| CL2023000451A1 (es) | 2023-10-20 |
| EP4196155A1 (en) | 2023-06-21 |
| KR20230051186A (ko) | 2023-04-17 |
| EP4196155A4 (en) | 2025-03-19 |
| CO2023002823A2 (es) | 2023-03-27 |
| BR112023002549A2 (pt) | 2023-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6896802B2 (ja) | 室温安定であるワクチンの乾燥製剤 | |
| CN101974484A (zh) | 一种人脐带间充质干细胞的制备方法 | |
| PE20140871A1 (es) | COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA | |
| CL2023000451A1 (es) | Vacunas vivas liofilizadas de bordetella | |
| CN104212733A (zh) | 一种光合细菌冻干保护剂 | |
| CN103316355A (zh) | 一种伪狂犬病活疫苗及制备方法 | |
| ES2269672T3 (es) | Vacuna contra mycoplasma inactivado por saponina. | |
| CN102626520A (zh) | 一种水貂犬瘟热活疫苗耐热冻干保护剂及制备方法 | |
| CN114767842A (zh) | 一种重组卡介苗的冻干制剂及其制备方法和用途 | |
| ES2362035B2 (es) | Cepa bacteriana cect7624, usos y producto xeroprotector producido por la misma. | |
| AR132234A1 (es) | Método para la fabricación de vacunas virales y composiciones de las mismas | |
| CN103981151B (zh) | 一种伪狂犬灭活疫苗及其制备方法 | |
| Souza et al. | Biopolymers in the preservation of rhizobacteria cells and efficiency in soybean inoculation | |
| Sierra-Moya et al. | Characterization of Fusarium species that affect the asparagus crops cultivation in Veracruz, Mexico. | |
| CN102380093A (zh) | 一种利用传代成纤维细胞生产鸡新城疫活疫苗的方法 | |
| Emmons et al. | Isolation of Histoplasma capsulatum from fresh and deep-frozen peribronchial lymph nodes of dogs by mouse inoculation | |
| MD1379Z (ro) | Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20 | |
| CN103301453A (zh) | 一种猪繁殖与呼吸综合征冻干疫苗及其制备方法 | |
| Zakutskii et al. | Immunobiological features of an attenuated African swine fever virus strain FK-135 grown in a porcine bone marrow cell suspension | |
| Shahzad | IMPACT OF GLYCEROL AND DIMETHYL SULFOXIDE ON THE PERSISTENCE OF PASTEURELLA MULTOCIDA DURING ITS PRESEVATION AT DIFFERENT TEMPERATURES | |
| RU2015131897A (ru) | Способ получения стерильной лиофилизированной добавки из личинок и куколок трутней | |
| RU2421512C1 (ru) | Питательная среда для культивирования энтомопатогенных грибов | |
| Ferreira et al. | Isolation and morphological characterization of bacteria of the genus Bradyrhizobium from agricultural plots of Loma Plata town, Boquerón-Paraguay | |
| MD1380Z (ro) | Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20 | |
| Berman et al. | Freeze-drying various attenuated strains of Pasteurella pestis |